Trials / Recruiting
RecruitingNCT00271180
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Medtronic CRDM Product Performance Report
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Medtronic · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
Detailed description
All Medtronic market-released leads and all market-released IPG, ICD and CRT devices are eligible to be included in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device |
Timeline
- Start date
- 1983-01-01
- Primary completion
- 2040-12-01
- Completion
- 2040-12-01
- First posted
- 2005-12-30
- Last updated
- 2025-12-17
Locations
318 sites across 35 countries: United States, Australia, Austria, Belgium, Canada, China, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, Saudi Arabia, Serbia, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT00271180. Inclusion in this directory is not an endorsement.